Industry News
WILEX AG has announced that pioneering study results on the Antibody Targeted Amanitin Conjugates (ATACs) technology have been published in the peer-reviewed journal Nature, in a report by the...
Sex, disease resistance linked to elite aging in study of oldest-living dogs
4/27/2015
To understand what it takes to live to be 100, scientists in the field of aging research have been enlisting help from the oldest-living humans.
Standard clinical assays can obscure the diversity of breast cancer subtypes
4/27/2015
Classification systems that categorize breast cancers based on estrogen receptor (ER), progesterone receptor (PR), and HER2 expression levels may obscure the heterogeneity of other key tumor...
Women with a rare type of breast cancer should be offered less invasive surgery where appropriate, according to new guidelines presented on Friday 24th April 2015 at the Inflammatory Breast Cancer...
Predictive genetic markers associated with breast cancer neuropathy identified
4/27/2015
Researchers at Roswell Park Cancer Institute (RPCI) have identified common inherited gene alterations that appear to make some patients more at risk of neurotoxicity when treated for breast cancer.
Mortality risks of cigar smoking similar to that of cigarette smoking
4/27/2015
Cigar smoking is associated with many of the same fatal conditions as cigarette smoking, according to research published in open access journal BMC Public Health.
Brain tumor growth stimulated by nerve activity in the cortex, Stanford study finds
4/27/2015
Deadly brain tumors called high-grade gliomas grow with the help of nerve activity in the cerebral cortex, according to a new study by researchers at the Stanford University School of Medicine.
Eligible for breast conserving therapy, many still choose mastectomy
4/27/2015
Improved chemotherapy treatments give more triple-negative breast cancer patients the choice of lumpectomyNo approved targeted therapies exist to treat triple-negative breast cancer, but new...
Form of permanent radiotherapy may prolong prostate cancer survival, study finds
4/27/2015
Compared with dose-escalated external beam radiotherapy, low-dose-rate prostate brachytherapy may prolong survival for patients with prostate cancer, a new study finds.
Toxic mushroom-based drug may help battle colorectal cancer
4/27/2015
MD Anderson study reveals role of gene called POLR2AFor some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment.